14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Philip Morris International (PM) Stock: Buy, Sell, or Hold?
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)50% (Hyper Growth)
EST. PRICE IN 2031
$251.73
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$156.31
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.8x Exit PE.
Valuation Analysis: PM is currently trading at $201.74, which is considered extended relative to its 30-day fair value range of $189.38 to $200.33. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.0) compared to its historical average (19.8). At these levels, the market is pricing in 3.6% annual earnings growth.
Technical Outlook: Technically, PM is in a strong uptrend. Immediate support is located at $184.00, while resistance sits at $210.45.
Market Sentiment: PM scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$189.38 -
$200.33
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
27.1%
Protect Your Profits
Holding PM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokable products but also gained a toehold in the US to sell its Iqos heated tobacco product.